Verition Fund Management
EDIT icon

Verition Fund Management’s Editas Medicine EDIT Stock Holding History

Verition Fund Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,074
Closed -$53.4K – 3415
2024
Q4 		$53.4K Buy
42,074
+19,084
+83% +$48.6K ﹤0.01% 3126
2024
Q3 		$78.4K Buy
+22,990
New +$100K ﹤0.01% 3024
2023
Q2 		– Sell
-17,169
Closed -$124K – 2287
2023
Q1 		$124K Buy
+17,169
New +$153K ﹤0.01% 1884
2022
Q4 		– Sell
-22,147
Closed -$271K – 2303
2022
Q3 		$271K Buy
+22,147
New +$345K ﹤0.01% 2293
2020
Q3 		– Sell
-9,943
Closed -$294K – 1132
2020
Q2 		$294K Buy
+9,943
New +$260K 0.01% 801
2020
Q1 		– Sell
-8,854
Closed -$262K – 724
2019
Q4 		$262K Buy
+8,854
New +$221K ﹤0.01% 866

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management's EDIT Position: Q1 2025 in Review

Verition Fund Management sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 42,074 shares — an estimated $53.4K sold.

Verition Fund Management first reported a position in EDIT in Q4 2019 and held it in 6 quarters. The position peaked at $294K in Q2 2020. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • Verition Fund Management reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 42,074 Editas Medicine shares in Q1 2025, an estimated $53.4K.
  • Verition Fund Management first reported a position in Editas Medicine in Q4 2019 and held it in 6 quarters.
  • Verition Fund Management's Editas Medicine position peaked at $294K in Q2 2020.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.